Announcement on Pledge of Shareholders' Shares
Filed with SSE · · 4 pages · Chinese
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jointown Pharmaceutical
- Announcement on Completion of Filing for Industrial Fund Established by Holding Grandchild Subsidiary
- Announcement on Outline of the Q3 2025 Performance Briefing
- Announcement on Resolutions of the 17th Meeting of the 6th Board of Directors
- Announcement on Entrusted Financial Management in Q3 2025
- Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase I) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
Later from Jointown Pharmaceutical
- Announcement on Progress in Court's Acceptance of the Reorganization and Appointment of a Administrator for Aoyuan Meigu Technology Co., Ltd., a Wholly-owned Subsidiary Participating in the Reorganization Investment
- Announcement on Issuance of the Phase I Asset-backed Notes for 2025 and Related Party Transactions
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Obtaining Drug Registration Certificate for Isopropylamine Hydrochloride Injection
- Announcement on Completion of Execution of Reorganization Plan of Aoyuan Beauty Valley Technology Co., Ltd., in Which the Wholly-owned Subsidiary Participated as a Reorganization Investor
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical